Vicki Moore, PhD

Contributing Writer https://www.thecardiologyadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

Multiple Myeloma

Adaptation to Bortezomib Treatment in Multiple Myeloma Cells

By

Vicki Moore, PhD

June 23, 2022

Researchers sought to characterize features of multiple myeloma cells that may be involved in treatment resistance to bortezomib.

vaccination in the arm

Transplantation

Varicella-Zoster Vaccination After Allogeneic Stem Cell Transplantation

By

Vicki Moore, PhD

June 22, 2022

Researchers sought to determine whether varicella-zoster virus vaccination with a recombinant vaccine would show results in patients who underwent HSCT.

A new study aims to address the conundrum of coagulation risk in patients hospitalized for hematologic malignancies.

Thromboprophylaxis Reduces Risk of VTE for Patients With Sickle Cell Disease and a Central Venous Access Device

By

Vicki Moore, PhD

May 19, 2022

Researchers sought to determine whether thromboprophylaxis would reduce venous thromboembolism risk in patients with SCD and a central venous access device.

Doctor talking to patient.

Transplantation

Sexual and Emotional Health Impacts of Allogeneic Hematopoietic Stem Cell Transplantation

By

Vicki Moore, PhD

April 29, 2022

Researchers sought to determine the impacts on sexual and emotional health following allogeneic hematopoietic stem cell transplantation.

General Medicine

Higher Symptom Burden More Likely to Improve With MPN Treatment

By

Vicki Moore, PhD

April 26, 2022

Analysis of data from 2 clinical trials sought to determine the effect on symptom burden of 2 common therapies for myeloproliferative neoplasms.

General Medicine

Endothelial Damage and Hypercoagulability With Moderate COVID-19

By

Vicki Moore, PhD

April 13, 2022

Researchers sought to determine whether there is a link between COVID-19 and endothelial damage and hypercoagulability.

General Medicine

COVID-19 Vaccination and Vaccine-Induced Immune Thrombotic Thrombocytopenia

By

Vicki Moore, PhD

February 15, 2022

Researchers sought to determine the pathology behind possible vaccine-induced immune thrombocytopenia and thrombosis following COVID-19 vaccinations.

Doctor using a computer.

Vascular Medicine

Characteristics Associated With Cerebral Venous Thrombosis in MPNs

By

Vicki Moore, PhD

September 14, 2021

Researchers characterized incidence and factors linked to cerebral venous thrombosis associated with myeloproliferative neoplasms.

Researchers interviewed clinicians and patients to develop a conceptual model of congenital thrombotic thrombocytopenic purpura.

Vascular Medicine

Analysis of the NEOCLOT Protocol for Catheter-Related Venous Thrombosis

By

Vicki Moore, PhD

August 10, 2021

Researchers evaluated the NEOCLOT protocol for management of catheter-related venous thrombosis in neonates in the Netherlands.

Hematology Advisor spoke with experts about the new ASH clinical practice guidelines for VTE.

Vascular Medicine

Risk Factors for Venous Thromboembolism in Adolescent Girls Receiving Hormonal Therapy

By

Vicki Moore, PhD

May 13, 2021

Researchers sought to identify and analyze risk factors for thrombosis in adolescent girls receiving hormonal therapy.

Next post in Vascular Medicine

Rare Adverse Thrombotic Events After ChAdOx1 nCov-19 Vaccination